AETHLON MEDICAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
AETHLON MEDICAL, INC. (AEMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 0 shares for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2024-11-13
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-09-30 was 0.00 shares.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-06-30 was 0.00 shares.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2023-12-31 was 0.00 shares.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2023-09-30 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month |
|---|---|---|---|
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-13 | 0.00 shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-14 | ||
| 2023-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-14 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-13 | 0.00 shares 10-Q · filed 2024-02-14 |
| 2023-09-30 | 0.00 shares 10-Q · filed 2024-11-13 | 0.00 shares 10-Q · filed 2024-11-13 | |
| 2023-06-30 | 0.00 shares 10-Q · filed 2024-08-14 | ||
| 2018-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-11 | 0.00 shares derived: sum of 2 quarters · filed 2019-02-11 | 0.00 shares 10-Q · filed 2019-02-11 |
| 2018-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-06 | 0.00 shares 10-Q · filed 2018-11-06 | |
| 2018-06-30 | 0.00 shares 10-Q · filed 2018-08-08 | ||
| 2015-06-30 | 0.00 shares 10-Q · filed 2016-08-11 | ||
| 2012-12-31 | 1.67M shares 10-Q · filed 2013-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |